Lithuanian Prostate Diagnostics Implementation Guide
0.0.1 - ci-build Lithuania flag

Lithuanian Prostate Diagnostics Implementation Guide, published by Lithuanian Medical Library. This guide is not an authorized publication; it is the continuous build for version 0.0.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7LT/ig-lt-prostate/ and changes regularly. See the Directory of published versions

: ConceptMap: Prostate pathology Questionnaire → FHIR mapping

Draft as of 2025-03-24

Raw json | Download

{
  "resourceType" : "ConceptMap",
  "id" : "conceptmap-prostate-pathology-questionnaire-to-fhir-lt-prostate",
  "language" : "en",
  "text" : {
    "status" : "generated",
    "div" : "<div xml:lang=\"en\" lang=\"en\"><hr/><p><b>English</b></p><hr/><p class=\"res-header-id\"><b>Generated Narrative: ConceptMap conceptmap-prostate-pathology-questionnaire-to-fhir-lt-prostate</b></p><a name=\"conceptmap-prostate-pathology-questionnaire-to-fhir-lt-prostate\"> </a><a name=\"hcconceptmap-prostate-pathology-questionnaire-to-fhir-lt-prostate\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Language: en</p></div><p>Mapping from (not specified) to (not specified)</p><br/><p><b>Group 1 </b>Mapping from <a href=\"CodeSystem-prostate-pathology-questionnaire-item.html\">Prostate pathology ESPBI Questionnaire item (linkId)version: 0.0.1)</a> to <a href=\"CodeSystem-prostate-fhir-mapping-target.html\">Prostate questionnaire → FHIR mapping target (illustrative)version: 0.0.1)</a></p><table class=\"grid\"><tr><td><b>Source Code</b></td><td><b>Relationship</b></td><td><b>Target Code</b></td><td><b>Comment</b></td></tr><tr><td>bioptate-length-mm (Bioptate length (mm))</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#related-to\" title=\"related-to\">is related to</a></td><td>specimen-dimension-or-measurement (Specimen / Observation specimen measurement (TumorMeasurementLtLab, gross))</td><td>Specimen dimension or Observation-observation-specimen-measurement-example (LT Lab).</td></tr><tr><td>specimen-quality (Quality of materials)</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#related-to\" title=\"related-to\">is related to</a></td><td>specimen-adequacy-finding (Observation: specimen adequacy (LT Lab))</td><td>Observation-observation-specimen-adequacy-example (LT Lab); map answerCoding to SNOMED finding codes from national spec.</td></tr><tr><td>treatment-effect (Treatment effect on tumour)</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#related-to\" title=\"related-to\">is related to</a></td><td>observation-tumor-treatment-effect (Observation: tumor treatment effect (TumorObservableLtLab))</td><td>TumorObservableLtLab or narrative in DiagnosticReport; map radiotherapy/hormone SNOMED from spreadsheet.</td></tr><tr><td>histological-type (Primary histological type)</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#related-to\" title=\"related-to\">is related to</a></td><td>condition-morphology-prostate (Condition / morphology (ProstateConditionLtLab, ICD-O))</td><td>Condition.code / morphology; Condition-condition-prostate-cancer-example (LT Lab) for integrated staging.</td></tr><tr><td>histological-comment (Histological type comment)</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#related-to\" title=\"related-to\">is related to</a></td><td>condition-morphology-prostate (Condition / morphology (ProstateConditionLtLab, ICD-O))</td><td>Condition.note or Observation.note; complements histological-type.</td></tr><tr><td>isup-grade-group</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#related-to\" title=\"related-to\">is related to</a></td><td>observation-gleason-isup-prostate (GleasonIsupObservationLtProstate + ProstateIsupGradeGroupVS)</td><td>GleasonIsupObservationLtProstate + ValueSet prostate-isup-grade-group. Example: Observation-observation-prostate-gleason-gradegroup-example.</td></tr><tr><td>idc-status (Intraductal carcinoma (IDC))</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#related-to\" title=\"related-to\">is related to</a></td><td>observation-tumor-microscopic-idc (TumorObservableLtLab / morphology for IDC)</td><td>TumorObservableLtLab / morphology Observation; national form has additional IDC sub-questions.</td></tr><tr><td>cribriform-status (Cribriform glands)</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#related-to\" title=\"related-to\">is related to</a></td><td>observation-tumor-microscopic-cribriform (TumorObservableLtLab / morphology for cribriform)</td><td>TumorObservableLtLab or structured finding Observation.</td></tr><tr><td>pattern4-pct-band (Pattern 4 quantity (percent band))</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#related-to\" title=\"related-to\">is related to</a></td><td>observation-pattern4-percent (Observation: Pattern 4 percent band (lab tumour measurement patterns))</td><td>TumorMeasurementLtLab or lab tumour Observation; dr-prostate has finer bands than this Questionnaire.</td></tr><tr><td>tumor-percent-in-biopsy (Tumour percentage in biopsy tissue)</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#related-to\" title=\"related-to\">is related to</a></td><td>observation-tumor-burden-percent (Observation: tumour percentage in biopsy tissue)</td><td>Quantitative tumour assessment row in dr-prostate; map to Observation ratio or coded category.</td></tr><tr><td>periprostatic-fat-invasion</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#related-to\" title=\"related-to\">is related to</a></td><td>observation-periprostatic-invasion (Observation: periprostatic fat / seminal vesicle invasion (LT Lab tumour findings))</td><td>NeoplasmInvasionLtProstate (imaging) vs microscopic finding in pathology Observation; use LT Lab tumour findings for biopsy.</td></tr><tr><td>perineural-invasion</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#related-to\" title=\"related-to\">is related to</a></td><td>observation-perineural-invasion (Observation: perineural invasion finding (LT Lab tumour findings))</td><td>SNOMED 369731000 (present), 370051000 (absent), 385001000 (not identified), 396393005 (indeterminate); use LT Lab tumour findings.</td></tr><tr><td>lymphovascular-invasion (Lymphatic and/or vascular tumour invasion)</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#related-to\" title=\"related-to\">is related to</a></td><td>observation-lymphovascular-invasion (Observation: lymphovascular invasion finding (LT Lab tumour findings))</td><td>SNOMED 385414009 Lymphatic (small vessel) tumor invasion finding; use LT Lab tumour findings for biopsy microscopic assessment.</td></tr></table></div>"
  },
  "url" : "https://hl7.lt/fhir/prostate/ConceptMap/prostate-pathology-questionnaire-to-fhir",
  "version" : "0.1.0",
  "name" : "ProstatePathologyQuestionnaireToFhir",
  "title" : "Prostate pathology Questionnaire items to FHIR mapping",
  "status" : "draft",
  "experimental" : true,
  "date" : "2025-03-24",
  "publisher" : "Lithuanian Medical Library",
  "contact" : [
    {
      "name" : "Lithuanian Medical Library",
      "telecom" : [
        {
          "system" : "url",
          "value" : "https://medicinosnk.lt"
        },
        {
          "system" : "email",
          "value" : "info@medicinosnk.lt"
        }
      ]
    }
  ],
  "description" : "Maps dr-prostate-aligned pathology Questionnaire linkIds to LT Lab and LT Prostate Gleason/ISUP patterns.",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "urn:iso:std:iso:3166",
          "code" : "LT"
        }
      ]
    }
  ],
  "group" : [
    {
      "source" : "https://tx.hl7.lt/fhir/CodeSystem/prostate-pathology-questionnaire-item|0.0.1",
      "target" : "https://tx.hl7.lt/fhir/CodeSystem/prostate-fhir-mapping-target|0.0.1",
      "element" : [
        {
          "code" : "bioptate-length-mm",
          "display" : "Bioptate length (mm)",
          "target" : [
            {
              "code" : "specimen-dimension-or-measurement",
              "relationship" : "related-to",
              "comment" : "Specimen dimension or Observation-observation-specimen-measurement-example (LT Lab)."
            }
          ]
        },
        {
          "code" : "specimen-quality",
          "display" : "Quality of materials",
          "target" : [
            {
              "code" : "specimen-adequacy-finding",
              "relationship" : "related-to",
              "comment" : "Observation-observation-specimen-adequacy-example (LT Lab); map answerCoding to SNOMED finding codes from national spec."
            }
          ]
        },
        {
          "code" : "treatment-effect",
          "display" : "Treatment effect on tumour",
          "target" : [
            {
              "code" : "observation-tumor-treatment-effect",
              "relationship" : "related-to",
              "comment" : "TumorObservableLtLab or narrative in DiagnosticReport; map radiotherapy/hormone SNOMED from spreadsheet."
            }
          ]
        },
        {
          "code" : "histological-type",
          "display" : "Primary histological type",
          "target" : [
            {
              "code" : "condition-morphology-prostate",
              "relationship" : "related-to",
              "comment" : "Condition.code / morphology; Condition-condition-prostate-cancer-example (LT Lab) for integrated staging."
            }
          ]
        },
        {
          "code" : "histological-comment",
          "display" : "Histological type comment",
          "target" : [
            {
              "code" : "condition-morphology-prostate",
              "relationship" : "related-to",
              "comment" : "Condition.note or Observation.note; complements histological-type."
            }
          ]
        },
        {
          "code" : "isup-grade-group",
          "display" : "ISUP grade group",
          "target" : [
            {
              "code" : "observation-gleason-isup-prostate",
              "relationship" : "related-to",
              "comment" : "GleasonIsupObservationLtProstate + ValueSet prostate-isup-grade-group. Example: Observation-observation-prostate-gleason-gradegroup-example."
            }
          ]
        },
        {
          "code" : "idc-status",
          "display" : "Intraductal carcinoma (IDC)",
          "target" : [
            {
              "code" : "observation-tumor-microscopic-idc",
              "relationship" : "related-to",
              "comment" : "TumorObservableLtLab / morphology Observation; national form has additional IDC sub-questions."
            }
          ]
        },
        {
          "code" : "cribriform-status",
          "display" : "Cribriform glands",
          "target" : [
            {
              "code" : "observation-tumor-microscopic-cribriform",
              "relationship" : "related-to",
              "comment" : "TumorObservableLtLab or structured finding Observation."
            }
          ]
        },
        {
          "code" : "pattern4-pct-band",
          "display" : "Pattern 4 quantity (percent band)",
          "target" : [
            {
              "code" : "observation-pattern4-percent",
              "relationship" : "related-to",
              "comment" : "TumorMeasurementLtLab or lab tumour Observation; dr-prostate has finer bands than this Questionnaire."
            }
          ]
        },
        {
          "code" : "tumor-percent-in-biopsy",
          "display" : "Tumour percentage in biopsy tissue",
          "target" : [
            {
              "code" : "observation-tumor-burden-percent",
              "relationship" : "related-to",
              "comment" : "Quantitative tumour assessment row in dr-prostate; map to Observation ratio or coded category."
            }
          ]
        },
        {
          "code" : "periprostatic-fat-invasion",
          "display" : "Periprostatic fat invasion",
          "target" : [
            {
              "code" : "observation-periprostatic-invasion",
              "relationship" : "related-to",
              "comment" : "NeoplasmInvasionLtProstate (imaging) vs microscopic finding in pathology Observation; use LT Lab tumour findings for biopsy."
            }
          ]
        },
        {
          "code" : "perineural-invasion",
          "display" : "Perineural invasion",
          "target" : [
            {
              "code" : "observation-perineural-invasion",
              "relationship" : "related-to",
              "comment" : "SNOMED 369731000 (present), 370051000 (absent), 385001000 (not identified), 396393005 (indeterminate); use LT Lab tumour findings."
            }
          ]
        },
        {
          "code" : "lymphovascular-invasion",
          "display" : "Lymphatic and/or vascular tumour invasion",
          "target" : [
            {
              "code" : "observation-lymphovascular-invasion",
              "relationship" : "related-to",
              "comment" : "SNOMED 385414009 Lymphatic (small vessel) tumor invasion finding; use LT Lab tumour findings for biopsy microscopic assessment."
            }
          ]
        }
      ]
    }
  ]
}